A difficult to treat brain tumor that occurs at the same rate in dogs, as it does in humans, will be the subject of canine clinical trials at the Vet School at Virginia Tech.
Glioblastomas are rapidly growing brain tumors, which typically affect older adults. They’re notoriously difficult to remove and hard to treat because they quickly develop resistance to chemotherapy.
The main drug used to fight them is known as T-M-Z. Scientists from Virginia Tech and Carilion Clinic did a study in which they added another drug to the mix called ACT 1.